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ABSTRACT
Background: Impedance cardiography (ICG) is a noninvasive hemodynamic monitoring tool which
can define hypertensive patients’ hemodynamic profiles and help to tailor antihypertensive therapy.
This study assesses the concordance between ICG-derived indexes used to evaluate left ventricular
performance and transthoracic echocardiography (TTE) in hypertensive patients. Methods: In this
IMPEDDANS post-hoc analysis, the ICG-derived indexes are compared with TTE by Bland–Altman
method. Statistical significance of the relationship between the values obtained was assessed by
generalized linear mixed-effects models. Results: In supine position, Bland–Altman analysis showed
good concordance for cardiac output (CO) (mean difference of 0.006 mL/min [−0.120; 0.133]), cardiac
index (CI) (mean difference of 0.016 mL/min/m2 [−0.471; 0.504]), pre-ejection period (PEP) (mean
difference of −0.216 ms [−4.510; 4.077]), left ventricular ejection time (LVET) (mean difference of
−0.140 ms [−6.573; 6.293]), and systolic time ratio (STR) (mean difference of −0.00004 [−0.008;
0.008]). In orthostatic position, good concordance was found for CO (mean difference 0.028 mL/
min [−2.036; 1.980]), CI (mean difference −0.012 mL/min/m2 [−1.063; 1.039]), and STR (mean
difference −0.101 [0.296; 0.094]). No significant difference between methods was identified by the
linear mixed-effects models. Conclusion: The ICG-derived indexes CO, CI, PEP, LVET, and STR in
supine position have good agreement with TTE. Therefore, ICG can be used to accurately evaluate
left ventricular performance.
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Impedance cardiography (ICG) has evolved in recent
years, it is already used in several setting (e.g., evaluation
of postural cardiac rehabilitation, pacemaker optimization,
sleep study, hemodynamic monitoring in pregnancy and
in the outpatient setting), and it has become an attractive
and economical alternative to the clinical approach to
hypertensive patients (1–7). ICG is a noninvasive hemo-
dynamic monitoring tool, nonoperator dependent and
non-expensive, which can characterize hemodynamic pro-
files and contribute to optimize antihypertensive therapy
(8,9). The use of ICG hemodynamic parameters has been
proposed to guide pharmacologic prescription according
to the pathophysiological mechanism involved in the sus-
tained elevation of blood pressure (BP) (10–15). This
personalized, guided hemodynamic therapy approach
reveals both efficacy and cost-effectivity (10–15).
The evolution of hypertensive heart disease toward heart
failure (HF) involves structural and geometry modifications
which can impair left ventricular (LV) function (9,16). Recent
reports suggest that the ICG-derived systolic time intervals
may be used to monitor impaired systolic and/or diastolic LV
function; however, there are conflicting results concerning the
screening of LV impairment and in the validation of the ICG-
derived indexes. Therefore, it is necessary to validate the
method in specific clinical settings (17–25). This study verifies
the agreement between ICG-derived indexes used in evaluat-




In this post-hoc analysis of data from the IMPEDDANS pro-
ject (Impedance Cardiography in the Evaluation of Left
Ventricular Diastolic dysfunction in Patients with Arterial
Hypertension Study), the ICG-derived indexes are compared
with contemporary transthoracic echocardiography (TTE)-
derived indexes, used nowadays as the clinical standard. The
cardiac output (CO), cardiac index (CI), pre-ejection period
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(PEP), left ventricular ejection time (LVET), and systolic time
ratio (STR) are assessed by ICG (in supine and orthostatic
positions) and TTE. The project protocol was approved by the
hospital’s Ethics Committee (approval number 166/2014).
Informed consent was obtained from each patient.
IMPEDDANS is registered on ClinicalTrials.gov (ID:
NCT03209141).
Sampling
Patients of either gender, aged 18–75 years, with grade 2 or 3
HT (systolic BP ≥ 160 mmHg and/or diastolic
BP ≥ 100 mmHg) and/or with resistant HT (according the
definition of ESH/ESC guidelines) (26), followed up in ambu-
latory clinic of an Internal Medicine Department of a tertiary
referral hospital were eligible for recruitment.
Patients were excluded in the presence of pregnancy,
height <120 cm or >230 cm, weight <30 kg or >155 kg, HF
II–IV NYHA (27), heart rate (HR) <50 bpm or >110 bpm,
atrial fibrillation or flutter, more than three premature ven-
tricular contractions per hour, complete left bundle branch or
atrioventricular block, pacemaker, severe valvulopathy, con-
strictive pericarditis, hypertrophic and restrictive cardiomyo-
pathy, ischemic heart disease and/or segmental kinetics
anomalies assessed by echocardiography, left ejection fraction
<50%, or poor echocardiographic window. Recruitment began
in January 2015 and was finished in July 2017.
Evaluations and data collection
Participants were invited to be systematically assessed by ICG
and echocardiography, with a maximum interval of 8 days in
between. To ensure that both tests were performed under
similar conditions, evaluations matching variations >10% in
BP or variations >5% in HR were not considered. These
patients were asked to repeat the tests. If the variations per-
sisted, they were excluded.
ICG was carried out by an experienced cardiopneumology
technician with Niccomo – Non-Invasive Continuous Cardiac
Output Monitor (Medis GmbH, Ilmenau, Germany) –
according the approved department protocol. Patients were
required to have 6 h of fasting but took their usual antihy-
pertensive drugs. With patients in dorsal decubitus, it was
carried out in supine position during 20 min (continuous
recording) and 70° orthostatism on a tilting table (10 min in
continuous recording). The test was interrupted whenever
occurred syncope or pre-syncope; dizziness, nausea, and
malaise associated with poorly tolerated hypotension and/or
bradycardia; pain/precordial discomfort; EKG ST segment
changes; systolic BP >210 mmHg.
TTE was performed in Vivid E9 and S5 devices (GE
Healthcare, Chicago, IL, USA) always by experienced cardiol-
ogists. To ensure uniformity of evaluation and correct evalua-
tion, all exams were reviewed by another independent
cardiologist. The exam was performed with the patients in
left lateral decubitus. CO was calculated based on measure-
ment of the flow velocity time integral (VTI) measured over
the aortic valve (AoV), measured from an apical four-cham-
ber view with angle correction, if necessary, multiplied by the
area of the AoV:CO = AoV area × VTI × HR, where the AoV
diameter was determined by triplicate measurements of the
internal diameter of the AoV hinge points: AoV
area = (0.5 × diameter)2 × 3.14 (28). LVET (ms) was mea-
sured as the duration of flow using standard pulsed wave
Doppler with sample volume in the LV outflow tract just
below the AoV leaflets. PEP (ms) was measured as the time
interval between R wave on ECG and beginning of LV out-
flow tract flow. The ratio of PEP to LVET was also
obtained (29).
The correlation between the parameters obtained by ICG
(both in supine and orthostatic positions) and TTE was
assessed by Spearman correlation test; the strength of correla-
tion was interpreted according to Hinkle et al (30). To eval-
uate the agreement between ICG (both in supine and
orthostatic positions) and TTE for measuring CO, CI, PEP,
LVET, and STR, Bland–Altman method was used.
Additionally, the statistical significance of the relationship
between the values obtained by ICG and TTE was assessed
using generalized linear mixed-effects models. The level of
significance α = 0.05 was considered. Data were analyzed
with Stata 11.0 (StataCorp. 2011, Stata Statistical Software:
Release 12. College Station, TX: StataCorp LP).
Results
IMPEDDANS study recruited 167 patients. Ten patients were
excluded: three had syncope during ICG, three gave up and
did not perform the tests, three had a significant dysrhythmia,
and one was diagnosed as having an atrial septal defect. From
the 157 hypertensive patients included, 102 (65%) had LV
diastolic dysfunction (diagnosed by echocardiogram).
Table 1 shows the main demographic and clinical character-
istics of the patients.
The values obtained by ICG (in both supine and ortho-
static positions) and by TTE are presented in Table 1. The
values of every parameter obtained by ICG in supine position
had a very high correlation with their equivalents obtained by
TTE; on the other hand, the TTE-derived parameters had low
or moderate correlation with the values obtained by ICG in
orthostatic position (Table 2 and Supplementary Figure 1).
Table 1. Main characteristics of the effective sample
(n = 157).
Males, n (%) 88 (56.1)
Age, mean (SD) 63 (10)
Caucasian, n (%) 142 (90.4)
HT duration (months), mean (SD) 120 (104)
Resistant HT, n (%) 117 (74.5)
Obesity, n (%) 82 (52.2)
Diabetes mellitus, n (%) 81 (51.6)
Dyslipidemia, n (%) 133 (84.7)
CKD, n (%) 49 (31.2)
Stroke, n (%) 36 (22.9)
COPD, n (%) 20 (12.7)
OSA, n (%) 31 (19.7)
Smoker, n (%) 34 (21.7)
Alcoholic, n (%) 16 (10.8)
No. of AHT drugs, median (min–max) 4 (1–7)
AHT: Antihypertensive; CKD: chronic kidney disease;
COPD: chronic obstructive pulmonary disease;
HT: hypertension.




























The Bland–Altman analysis showed a good concordance
between the values of the parameters obtained by TTE and by
ICG in supine position (Figure 1(a–e)): for CO, the mean
difference was 0.006 mL/min (limits of agreement −0.120–
0.133); for CI, mean difference 0.016 mL/min/m2 (−0.471–
0.504); for PEP, mean difference −0.216 ms (−4.510–4.077);
LVET, mean difference −0.140 ms (−6.573–6.293); and STR,
mean difference −0.00004 (−0.008–0.008).
The Bland–Altman analysis of the values of the para-
meters obtained by TTE and by ICG in orthostatic position
(Figure 1(f–j)) showed good concordance for CO (mean
difference 0.028 mL/min; limits of agreement −2.036–
1.980) and CI (mean difference −0.012 mL/min/m2; limits
of agreement −1.063–1.039). The agreement was worse for
PEP (mean difference −22.649 ms; limits of agreement
−66.316–21.017), LVET (mean difference of 25.617 ms; lim-
its of agreement −73.194–124.429), and STR (mean differ-
ence −0.101; limits of agreement −0.296–0.094).
The linear mixed effects models identified no significant
difference between the TTE-derived values and those obtained
by ICG performed in supine position, in any of the para-
meters (p = 0.214–0.890). For the parameters obtained by ICG
performed in orthostatic position, a significant difference to
the TTE-derived values was found for PEP, LVET, and STR
(p < 0.001) (Table 3).
Discussion
This study found good agreement (Bland–Altman analysis)
between the TTE-derived parameters (CO, CI, PEP, LVET,
STR) and those ICG-derived evaluated in supine position. The
agreement of TTE-derived parameters and those ICG-derived
evaluated in orthostatic position was acceptable for CO and
CI but low for PEP, LVET, and STR. These results demon-
strate that the ICG in supine position can be used as a reliable
and cost-effective alternative for evaluation and monitoring
LV performance-derived indexes.
The good agreement found between these two methods
may help to reduce doubts about the usefulness of ICG in
hypertensive patients. Although there are many published
articles about the benefits of ICG and its applicability, there
are issues that have conditioned its overall use. Most studies
carried out had small samples, the accuracy and reproduci-
bility of each variable was differently determined between
trials, and results were conflicting (25). TTE has rarely been
used as a reference method to analyze the agreement of the
parameters evaluated by ICG and studies presented different
results with correlation coefficients ranging from 0.27 to 0.95
(25,31–35).
There are few studies that evaluate the concordance of
other parameters besides CO (25). In literature, we find
three meta-analysis that group almost all studies that compare
the agreement of CO evaluated by ICG with other reference
methods. Fuller et al. analyzed 28 studies comparing ICG with
the Fick and thermodilution methods and concluded that ICG
had a correlation coefficient of 0.81 (36). Raaijmakers et al., in
a meta-analysis of 112 studies, determined a correlation coef-
ficient of 0.82 (37). Recently, Peyton and colleagues con-
ducted a new meta-analysis of studies comparing ICG,
esophageal Doppler, pulse-wave contour analysis, and the
Fick method with thermodilution (38). These authors report
a correlation coefficient of 0.79 and low mean difference for
ICG revealing better agreement than the other noninvasive
methods (38).
Despite these favorable results, some studies have shown a
low correlation between ICG and the various methods of
hemodynamic evaluation, namely in obese patients, in
patients with HF, chronic obstructive pulmonary disease,
aortic valvulopathy, dysrhythmia, in septic patients, under
mechanical ventilation, post cardiac surgery, among others
(39–43). Signal interference, hardware problems that impaired
signal sensitivity, or even the incorrect placement of the
electrodes are also potential biases in the ICG evaluations
(44–46). The technological developments that have been
introduced proved to be effective in their resolution, and trials
conducted with newer monitors have shown good agreement
with other methods (43,47).
Thus, we attribute the good agreement found in this study,
with correlation coefficients higher than the global values
found in the previous studies (r = 0.99) and with low mean
differences and agreement limits, to the fact that we excluded
factors that influence the evaluations by ICG such as the
presence of HF, significant valvulopathy, moderate-to-severe
chronic obstructive pulmonary disease, dysrhythmias, among
others comorbidities which could bias the evaluations; we
included only ambulatory patients; we used a new generation
monitor; we performed both examinations according to an
well-defined protocol and in a controlled clinical setting, by
expert practitioners.
Furthermore, previous studies report good reproducibility
of the evaluations performed on the same day but only accep-
table reproducibility when performed on different days
(r = 0.65–0.86) (48–50). The fact that our protocol establishes
that the examinations had to be performed in a short period
of time (8 days) and that patients could not present variations
Table 2. Cardiac output, cardiac index, pre-ejection period, left ventricular ejection time, and systolic time ratio obtained by ICG (in supine [s] and orthostatic [o]
positions) and by transthoracic echocardiography values.
ICGs ICGo TTE Correlation TTE:ICGs (r) Correlation TTE:ICGo (r)
CO (mL/min), median (P25–P75) 5.2 (4.3–6.0) 5.3 (4.5–6.0) 5.2 (4.4–6.0) 0.998 0.577
CI (mL/min/m2), median (P25–P75) 2.7 (2.4–3.5) 2.8 (2.5–3.1) 2.7 (2.4–3.1) 0.996 0.437
PEP (ms), median (P25–P75) 93 (79–105) 117 (99–133) 93 (79–104) 0.991 0.533
LVET (ms), median (P25–P75) 332 (291–369) 307 (268–332) 330 (292–369) 0.997 0.491
STR, median (P25–P75) 0.28 (0.24–0.33) 0.39 (0.32–0.46) 0.28 (0.24–0.33) 0.996 0.455
CI: Cardiac index; CO: cardiac output; LVET: left ventricular ejection time; PEP: pre-ejection period; STR: systolic time ratio; TTE: transthoracic echocardiography.
Correlations calculated with Spearman index (r).




























Figure 1. Agreement of the indexes used to evaluate left ventricular performance obtained by TTE and by ICG, both in supine and orthostatic positions. (a) Cardiac output in
supine position, (b) cardiac index in supine position, (c) pre-ejection period in supine position, (d) left ventricular ejection time in supine position, (e) systolic time ratio in
supine position, (f) cardiac output in orthostatic position, (g) cardiac index in orthostatic position, (h) pre-ejection period in orthostatic position, (i) left ventricular ejection
time in orthostatic position, and (j) systolic time ratio in orthostatic position.
CI: Cardiac index; CO: cardiac output; ICG: impedance cardiography; LVET: left ventricular ejection time; PPE: pre-ejection period; STR: systolic time ratio;
TTE: transthoracic echocardiography.




























greater than 5% in HR and 10% in BP, by minimizing hemo-
dynamic variability, may also have contributed to this good
agreement between methods.
The evaluation of the hemodynamic response to postural
change from supine to upright position provides useful infor-
mation on the cardiovascular reflex activity (51). The change
from supine to orthostatic position in healthy individuals
provokes reduction in thoracic blood volume and stroke
volume with subsequent decrease pressure on carotid baror-
eceptors which then causes a rise in HR and posterior sympa-
thetic vasoconstriction with BP normalization. Associated to
the high HR, the systolic time intervals usually decrease
(52,53).
Most of the studies were designed to study syncope and
therefore differences in orthostatic hemodynamics have not
been truly explored among hypertensive patients (54). It was
found that age was a major determinant of the response to
orthostatism, as those with stable stroke volume and CO were
mostly older hypertensive patients eventually related with
impaired carotid baroreflex or impaired autonomic balance
between arterial and cardiopulmonary baroreflexes (51).
The sample in the present study has many resistant, poly-
medicated, hypertensive patients with multiple comorbidities,
such as diabetes mellitus, which may affect the hemodynamic
response to orthostatism. This may contribute to the great
dispersion detected for ICG-derived indexes (PEP, LVET,
STR) and may explain the poor agreement between ICG-
derived indexes in orthostatic position and those obtained
by TTE, which is performed in supine position.
Echocardiographic measures of LV structure, morphology,
and function still continue to be important in the evaluation
of heart damage in hypertension (26). However, the signifi-
cant differences found between ICG-derived indexes in
supine/orthostatic position and TTE evaluations indicate
that the individual analysis of hypertensive patients with
ICG in both positions may add information about the
patients’ pathophysiological response, improving their hemo-
dynamic characterization and therapeutic optimization.
Future studies in the area of ICG may increase our under-
standing of the pathophysiology and hemodynamic changes
of arterial hypertension, in particular the importance of pos-
tural variability, and evidence that early diagnosis and treat-
ment of these hemodynamic characteristics have a positive
impact on patient outcomes, reducing morbidity and mortal-
ity associated with arterial hypertension.
This study had some limitations. This is a concordance
analysis, not strictly a validation study, as the ICG-derived
parameters are compared with TTE-derived parameters,
which is not the gold standard, but the current clinical stan-
dard. It is a post-hoc analysis, based on data obtained for a
study whose sample size was intended to reach a different
goal. ICG and TTE were performed not simultaneously but
within a time lapse of 8 days, a period during which the
patients were assumed to remain clinically stable, without
any changes of therapy. In order to minimize these weak-
nesses, a special effort was paid to guarantee the validity of the
measurements. Sampling had strict inclusion and exclusion
criteria; patients were submitted to the same well-defined
evaluation protocols, performed in a controlled clinical envir-
onment by experienced professionals. Moreover, evaluations
matching variations >10% in BP or variations >5% in HR
were not considered.
Conclusions
There is strong evidence that ICG performed in supine posi-
tion can accurately evaluate LV performance in hypertensive
patients, as ICG-derived systolic time intervals, CO, and CI
have good agreement with the parameters obtained by the
clinical standard (TTE).
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